192 related articles for article (PubMed ID: 1633172)
21. Replacement of Asp-162 by Ala prevents the cooperative transition by the substrates while enhancing the effect of the allosteric activator ATP on E. coli aspartate transcarbamoylase.
Fetler L; Tauc P; Baker DP; Macol CP; Kantrowitz ER; Vachette P
Protein Sci; 2002 May; 11(5):1074-81. PubMed ID: 11967364
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of new transition-state analogue inhibitors of aspartate transcarbamylase.
Farrington GK; Kumar A; Wedler FC
J Med Chem; 1985 Nov; 28(11):1668-73. PubMed ID: 4067992
[TBL] [Abstract][Full Text] [Related]
23. Discrimination between nucleotide effector responses of aspartate transcarbamoylase due to a single site substitution in the allosteric binding site.
Corder TS; Wild JR
J Biol Chem; 1989 May; 264(13):7425-30. PubMed ID: 2651439
[TBL] [Abstract][Full Text] [Related]
24. Evidence from 13C NMR for protonation of carbamyl-P and N-(phosphonacetyl)-L-aspartate in the active site of aspartate transcarbamylase.
Roberts MF; Opella SJ; Schaffer MH; Phillips HM; Stark GR
J Biol Chem; 1976 Oct; 251(19):5976-85. PubMed ID: 9410
[TBL] [Abstract][Full Text] [Related]
25. Function of threonine-55 in the carbamoyl phosphate binding site of Escherichia coli aspartate transcarbamoylase.
Xu W; Kantrowitz ER
Biochemistry; 1989 Dec; 28(26):9937-43. PubMed ID: 2515892
[TBL] [Abstract][Full Text] [Related]
26. Glu-50 in the catalytic chain of Escherichia coli aspartate transcarbamoylase plays a crucial role in the stability of the R quaternary structure.
Tauc P; Keiser RT; Kantrowitz ER; Vachette P
Protein Sci; 1994 Nov; 3(11):1998-2004. PubMed ID: 7703847
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA).
Jayaram HN; Cooney DA; Vistica DT; Kariya S; Johnson RK
Cancer Treat Rep; 1979 Aug; 63(8):1291-302. PubMed ID: 476706
[TBL] [Abstract][Full Text] [Related]
28. A loop involving catalytic chain residues 230-245 is essential for the stabilization of both allosteric forms of Escherichia coli aspartate transcarbamylase.
Middleton SA; Stebbins JW; Kantrowitz ER
Biochemistry; 1989 Feb; 28(4):1617-26. PubMed ID: 2655696
[TBL] [Abstract][Full Text] [Related]
29. Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.
Chadwick M; Silveira DM; MacGregor JA; Branfman AR; Liss RH; Yesair DW
Cancer Res; 1982 Feb; 42(2):627-32. PubMed ID: 7055806
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
[TBL] [Abstract][Full Text] [Related]
31. The allosteric activator ATP induces a substrate-dependent alteration of the quaternary structure of a mutant aspartate transcarbamoylase impaired in active site closure.
Baker DP; Fetler L; Vachette P; Kantrowitz ER
Protein Sci; 1996 Nov; 5(11):2276-86. PubMed ID: 8931146
[TBL] [Abstract][Full Text] [Related]
32. Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity.
Kensler TW; Erlichman C; Jayaram HN; Tyagi AK; Ardalan B; Cooney DA
Cancer Treat Rep; 1980; 64(8-9):967-73. PubMed ID: 7448831
[TBL] [Abstract][Full Text] [Related]
33. Complex of N-phosphonacetyl-L-aspartate with aspartate carbamoyltransferase. X-ray refinement, analysis of conformational changes and catalytic and allosteric mechanisms.
Ke HM; Lipscomb WN; Cho YJ; Honzatko RB
J Mol Biol; 1988 Dec; 204(3):725-47. PubMed ID: 3066911
[TBL] [Abstract][Full Text] [Related]
34. 2.5 A structure of aspartate carbamoyltransferase complexed with the bisubstrate analog N-(phosphonacetyl)-L-aspartate.
Krause KL; Volz KW; Lipscomb WN
J Mol Biol; 1987 Feb; 193(3):527-53. PubMed ID: 3586030
[TBL] [Abstract][Full Text] [Related]
35. L-alanosine: a noncooperative substrate for Escherichia coli aspartate transcarbamylase.
Baillon J; Tauc P; Hervé G
Biochemistry; 1985 Dec; 24(25):7182-7. PubMed ID: 3910096
[TBL] [Abstract][Full Text] [Related]
36. Changes in the hydrogen exchange kinetics of Escherichia coli aspartate transcarbamylase produced by effector binding and subunit association.
Lennick M; Allewell NM
Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6759-63. PubMed ID: 7031660
[TBL] [Abstract][Full Text] [Related]
37. An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues.
Cooney DA; Karlowicz MG; Cubillan J; Roettger M; Jayaram HN
Cancer Treat Rep; 1978 Oct; 62(10):1503-7. PubMed ID: 361225
[TBL] [Abstract][Full Text] [Related]
38. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
[TBL] [Abstract][Full Text] [Related]
39. Kinetic mechanism of catalytic subunits (c3) of E. coli aspartate transcarbamylase at pH 7.0.
Hsuanyu Y; Wedler FC
Biochim Biophys Acta; 1988 Dec; 957(3):455-8. PubMed ID: 3058211
[TBL] [Abstract][Full Text] [Related]
40. X-ray scattering titration of the quaternary structure transition of aspartate transcarbamylase with a bisubstrate analogue: influence of nucleotide effectors.
Fetler L; Tauc P; Hervé G; Moody MF; Vachette P
J Mol Biol; 1995 Aug; 251(2):243-55. PubMed ID: 7643401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
